Company: CERO
Filing Date: 2025-10-23
Form Type: 424B3
Source: 0001213900-25-101651
Chunk: 11

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-23
Form: 424B3
Chunk 11
---
ii) financial position, business strategy
and the plans and objectives of management for future operations of the Company, and the implementation of its proposed plan of compliance
with Nasdaq continued listing standards. These statements constitute projections, forecasts and forward-looking statements, and are not
guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts.
When used in this communication, words such as “anticipate,” “believe,” “continue,” “could,”
“estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,”
“potential,” “predict,” “project,” “should,” “strive,” “would”
and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not
forward-looking. When the Company discusses its strategies or plans, it is making projections, forecasts or forward-looking statements.
Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, the Company’s
management.

Actual results could differ from those implied
by the forward-looking statements in this Current Report on Form 8-K. Certain risks that could cause actual results to differ are set
forth in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, filed on April
15, 2025, and subsequent Quarterly Reports on Form 10-Q and the documents incorporated by reference therein. The risks described in the
Company’s filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time, and
it is not possible to predict all such risk factors, nor can the Company assess the impact of all such risk factors on its business, or
the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking
statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which
speak only as of the date hereof. All forward-looking statements made by the Company or persons acting on its behalf are expressly qualified
in their entirety by the foregoing cautionary statements. The Company undertakes no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law.

<div align='center'>5

SIGNATURE</div>

Pursuant to the requirements
of the Securities Exchange Act